LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis
暂无分享,去创建一个
[1] L. Miao,et al. LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer , 2021, BMC cancer.
[2] E. Semina,et al. MicroRNAs in Cancer: From Gene Expression Regulation to the Metastatic Niche Reprogramming , 2021, Biochemistry (Moscow).
[3] Lili Yang,et al. Long non-coding RNA SNHG20 promotes colorectal cancer cell proliferation, migration and invasion via miR-495/STAT3 axis , 2020, Molecular medicine reports.
[4] Peifeng Li,et al. Autophagy in cardiovascular diseases: role of noncoding RNAs , 2020, Molecular therapy. Nucleic acids.
[5] C. Ricciardelli,et al. Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype , 2020, International journal of molecular sciences.
[6] D. Ma,et al. Lidocaine inhibits the metastatic potential of ovarian cancer by blocking NaV1.5‐mediated EMT and FAK/Paxillin signaling pathway , 2020, Cancer medicine.
[7] Xiuli Wang,et al. LncRNA SNHG20 promoted proliferation, invasion and inhibited cell apoptosis of lung adenocarcinoma via sponging miR‐342 and upregulating DDX49 , 2020, Thoracic cancer.
[8] A. Rustgi,et al. EMT, MET, Plasticity, and Tumor Metastasis. , 2020, Trends in cell biology.
[9] Yi Ding,et al. Knockdown SNHG20 Suppresses Nonsmall Cell Lung Cancer Development by Repressing Proliferation, Migration and Invasion, and Inducing Apoptosis by Regulating miR-2467-3p/E2F3. , 2020, Cancer biotherapy & radiopharmaceuticals.
[10] Chunlei Yuan,et al. EMT related circular RNA expression profiles identify circSCYL2 as a novel molecule in breast tumor metastasis , 2020, International journal of molecular medicine.
[11] Shiqing Ma,et al. SNHG20: A vital lncRNA in multiple human cancers , 2019, Journal of cellular physiology.
[12] Fangfang Sheng,et al. ROCK1 promotes migration and invasion of non-small-cell lung cancer cells through the PTEN/PI3K/FAK pathway , 2019, International journal of oncology.
[13] N. Dhalla,et al. Emerging role of non-coding RNAs and extracellular vesicles in cardioprotection by remote ischemic conditioning of the heart. , 2019, Reviews in cardiovascular medicine.
[14] D. Park,et al. The effects of vaginal lubricants on the human vagina: an in vitro analysis , 2019, Clinical and Experimental Obstetrics & Gynecology.
[15] Yu Hongmei,et al. MicroRNA-362-3p attenuates motor deficit following spinal cord injury via targeting paired box gene 2. , 2019 .
[16] Min Zhang,et al. MicroRNA-362-3p attenuates motor deficit following spinal cord injury via targeting paired box gene 2. , 2019, Journal of integrative neuroscience.
[17] Dandan Wang,et al. LncRNA SNHG20 predicts a poor prognosis and promotes cell progression in epithelial ovarian cancer , 2019, Bioscience reports.
[18] M. Yaldız,et al. MMP7 and YKL-40 expressions in endometrial endometrioid carcinomas , 2019 .
[19] Huayao Li,et al. The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas , 2018, Cancer management and research.
[20] Yuanyuan Zhou,et al. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells , 2018, Cellular Physiology and Biochemistry.
[21] Wei Wang,et al. The interaction of Lin28A/Rho associated coiled-coil containing protein kinase2 accelerates the malignancy of ovarian cancer , 2018, Oncogene.
[22] Xia Li,et al. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis , 2018, Journal of Experimental & Clinical Cancer Research.
[23] E. Beltrão,et al. Identification of appropriate housekeeping genes for quantitative RT-PCR analysis in MDA-MB-231 and NCI-H460 human cancer cell lines under hypoxia and serum deprivation , 2018, Journal of Molecular and Clinical Medicine.
[24] Qing Yang,et al. Coexpression network analysis identified Krüppel‐like factor 6 (KLF6) association with chemosensitivity in ovarian cancer , 2018, Journal of cellular biochemistry.
[25] A. Vral,et al. Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2-associated hereditary breast and ovarian cancer reveals multiple co-acting second hits. , 2018, Cancer letters.
[26] Yong Wang,et al. Long non‐coding RNA NEAT1 promoted ovarian cancer cells’ metastasis through regulation of miR‐382‐3p/ROCK1 axial , 2018, Cancer science.
[27] Hongyu Jing,et al. A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer , 2018, Medical science monitor : international medical journal of experimental and clinical research.
[28] W. Cui,et al. Long Noncoding RNA Small Nucleolar RNA Host Gene 1 (SNHG1) Promotes Renal Cell Carcinoma Progression and Metastasis by Negatively Regulating miR-137 , 2018, Medical science monitor : international medical journal of experimental and clinical research.
[29] Xia Liu,et al. Low expression of KCNN3 may affect drug resistance in ovarian cancer , 2018, Molecular medicine reports.
[30] L. Du,et al. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer , 2018, Molecular oncology.
[31] G. Jiang,et al. FPPS mediates TGF-β1-induced non-small cell lung cancer cell invasion and the EMT process via the RhoA/Rock1 pathway. , 2018, Biochemical and biophysical research communications.
[32] Hong-wei Shen,et al. Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling , 2017, Bioscience reports.
[33] Publisher's Note , 2018, Anaesthesia.
[34] Honghao Li,et al. Activation of the ROCK1/MMP-9 pathway is associated with the invasion and poor prognosis in papillary thyroid carcinoma. , 2017, International journal of oncology.
[35] Xiaoling Li,et al. MicroRNA-148a Acts as a Tumor Suppressor in Osteosarcoma via Targeting Rho-Associated Coiled-Coil Kinase. , 2017, Oncology research.
[36] J. Qin,et al. HIC1 loss promotes prostate cancer metastasis by triggering epithelial–mesenchymal transition , 2017, The Journal of pathology.
[37] Yuan Li,et al. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells , 2017, BMC Cancer.
[38] R. Wenham,et al. Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study. , 2017, Gynecologic oncology.
[39] Guillermo A. Gomez,et al. ROCK1 but not ROCK2 contributes to RhoA signaling and NMIIA-mediated contractility at the epithelial zonula adherens , 2017, Molecular biology of the cell.
[40] Yuan Gao,et al. Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[41] Hongwei Liang,et al. MicroRNA-148a Suppresses the Proliferation and Migration of Pancreatic Cancer Cells by Down-regulating ErbB3. , 2016, Pancreas.
[42] Min Zhao,et al. Suppressive Role of MicroRNA-148a in Cell Proliferation and Invasion in Ovarian Cancer Through Targeting Transforming Growth Factor-β-Induced 2 , 2016, Oncology research.
[43] Yingyan Yu,et al. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer , 2016, PloS one.
[44] D. Brann,et al. Protective effect of Ac-SDKP on alveolar epithelial cells through inhibition of EMT via TGF-β1/ROCK1 pathway in silicosis in rat. , 2016, Toxicology and applied pharmacology.
[45] Yang Chen,et al. Insight Into the Role of Long Noncoding RNA in Cancer Development and Progression. , 2016, International review of cell and molecular biology.